27. The Commission shall assume the cost of a transcutaneous nerve stimulator having the following characteristics:(1) 2 channels;
(2) direct current;
(3) biphasic square waves;
(4) variable frequencies adjustable from 2 to 80 cycles per second;
(5) impulses adjustable between 50 and 250 micro-seconds;
(6) frequency modulator.